1. markmcginty13116
2. StockCats12
3. michaelj67
4. DontGiveMeLip
5. ghp9345
1.DontGiveMeLip 10/18/2017
I don't think many people realize what this is worth if it works.
2.StockCats12 10/18/2017
{Image}
3.dsau1268 04/04/2018
What Spooked Conatus Pharmaceuticals (CNAT) Investors This Evening
4.StockCats12 03/01/2018
Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results
5.ghp9345 04/05/2018
Conatus Pharmaceuticals (CNAT): Oppenheimer Advises Investors to Wait for the Next Catalyst
6.ghp9345 04/04/2018
Company reports top-line results from phase 2b POLT-HCV-SVR clinical trial; biopsy-based proof of concept in…
7.StockCats12 10/18/2017
$CNAT When you compare market cap of $MDGL ~600M with just phase 2 proof of concept study for NASH...CNAT should be higher than ~160M Good pipeline and A1 science but needs to prove it so might take a
8.eddiebaez 03/05/2018
Oppenheimer Has a New Play for Biotech Fans: Conatus Pharmaceuticals Inc (CNAT)
9.michaelj67 02/08/2018
Roth Capital initiates
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW